Lyell to Highlight Vision for its Next-Generation CAR
Accelerating IMPT-314 in large B-cell lymphoma; remain on track to initiate pivotal trial in the 3rd line+ setting in 2025...
Accelerating IMPT-314 in large B-cell lymphoma; remain on track to initiate pivotal trial in the 3rd line+ setting in 2025...
Since 2007, the halls of West Tennessee Healthcare (WTH) have been filled with more than just the hustle and bustle...
1 Introduction According to the International Labor Organization, an occupational injury is “an unexpected and unplanned event, including acts of...
Publish date: 24 January 2025 First Occupational Therapy apprentice to graduate from Northumbria Healthcare. Beth Green has become the first...
As the regulation of genetic modification is changing in European Parliament1, the CRISPR-Cas9 gene-editing technology divides opinion. A source of...
Immuneel Therapeutics on Monday launched Qartemi, a CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL). According to the company’s...
"CRISPR is a gene-editing tool that makes precise DNA changes, advancing drug development, crop improvement, and disease research. It opens...
The Singapore hospital combines expertise from ENT, psychiatry, and respiratory medicine.Snoring, often dismissed as a harmless quirk of sleep-deprived Singaporeans,...
Introduction The Aromatherapy Oils Market is projected to expand from USD 23.6 billion in 2023 to USD 51.9 billion by...